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Distinctive Biochemical Pattern
Associated with Resistance of
Hepatocytes in Hepatocyte Nodules
during Liver Carcinogenesis
by L. Eriksson,* M. Ahluwalia,* J. Spiewak,* G. Lee,*
D. S. R. Sarma,* M. J. Roomi* and E. Farber*
Hepatocyte ("hyperplastic") nodules induced in the liver by initiation with diethylnitrosamine
and selected by dietary 2-acetylaminofluorene plus partial hepatectomy ("resistant hepatocyte
model") have a special pattern of biochemical behavior and metabolic activity different than that
seen acutely with many xenobiotics including many promoting agents and carcinogens. The nodule
cells show a very low uptake of 2-acetylaminofluorene, relative to surrounding and normal liver, low
levels of activity in the cytochromes P-450 and aryl hydrocarbon hydroxylase, high levels of activity
in y-glutamyltransferase, microsomal epoxide hydrolase, soluble glutathione-S-transferase and
soluble UDP-glucuronyltransferase (UDP-GTJ) and elevated levels of glutathione. This metabolic
pattern appears to maximize the resistance of the nodules to xenobiotics generally, such as 2-ace-
tylaminofluorene, and thereby may account for the resistant behavior of nodule hepatocytes to the
inhibition of cell proliferation and the cytotoxicity by 2-acetylaminofluorene and other carcinogens.
The possible importance of this seemingly new metabolic program in carcinogenesis is discussed
briefly.
Introduction
It is becoming increasingly attractive to consider
that at least two patterns of development of liver
cancer probably exist in rats with several chemical
carcinogens. These may be designated (a) the
chronic enzyme induction model, and (b) the resis-
tant hepatocyte model.
The chronic enzyme induction model utilizes a
brief exposure to one of several carcinogens to in-
duce initiation, followed by a relatively long (2 to 7
months or longer) exposure to one of several differ-
ent promoters (1-3). The latter are by themselves
either noncarcinogenic or at most weakly carcino-
genic. So far, all the promoters such as phenobarbi-
tal (PB) (1, 4-6), polychlorinated biphenyls (PCBs) (7-
9), DDT (10), butylated hydroxytoluene (BGT) (11
and others (3) have been shown to be very effective
enzyme inducers in the liver. This is associated of-
ten with a considerable enlargement of the whole
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liver, due mainly to hypertrophy but also to some
hyperplasia (3).
The resistant hepatocyte model utilizes a brief
exposure to an initiating dose of one of many differ-
ent carcinogens to induce resistant liver cells (12,
13) followed by the selection of resistant hepato-
cytes to form focal proliferations variously desig-
nated as hyperplastic nodules, neoplastic nodules,
adenomas or simply hepatocyte nodules. The selec-
tion or "clonal expansion" is accomplished by a
short exposure to another carcinogen, such as 2-ace-
tylaminofluorene (2-AAF) (14-16) and others (15, 16)
coupled with a stimulus for liver proliferation, such
that the resistant cells scattered apparently ran-
domly throughout the liver undergo 10 or more
cycles of cell proliferation while the surrounding
cells are largely inhibited by the carcinogen. This
brief exposure (1 to 2 weeks) to the second carcino-
gen is sufficient not only to induce nodule formation
but also to set in motion a sequence of unknown
changes in a small subset of nodules ("persistent
nodules") that leads to hepatocellular carcinoma in
70 to 90% of rats by 8 to 10 months (17). A direct
linear sequence between resistant hepatocytes, nod-ERIKSSON ETAL.
ules and metastasizing cancer has been established,
although there is yet no way to predict which par-
ticular expanded clone (nodule) will evolve into can-
cer (18). Two particularly valuable properties of this
model are the relatively high degree of synchrony
of the resistant cells during the genesis of nodules
and the predictability in the biological findings and
behavior as a function of time during the first 8 to
10 weeks.
It is noteworthy that there is an apparent antago-
nism between the two models. Several of the agents
that are effective promoters when used after initia-
tion are also effective inhibitors of liver cancer de-
velopment when used with carcinogens. Thus, they
can be either promoters or anticarcinogens, depend-
ing upon the conditions of their use. The mecha-
nisms of these dual, seemingly contradictory, effects
have yet to be clarified.
The present study was designed to obtain more
insight into the biochemical basis for the resistance
in the new population of hepatocytes induced by di-
ethylnitrosamine (DENA) or 2-AAF and selected by
dietary 2-AAF plus partial hepatectomy (PH). Since
resistant hepatocytes generated during initiation
cannot as yet be harvested until they are stimu-
lated to proliferate, the entire emphasis on resis-
tance has focused on nodules. The special and per-
haps unique biochemical or metabolic pattern associ-
ated with this resistant hepatocyte population is the
subject ofthis communication.
Experimental
Male Fischer 344 or Wistar rats (Charles River
Breeding Laboratories, Inc., Wilmington, MA) ini-
tially weighing 150 to 170 g were used. The rats
were maintained on a high protein (24%) basal diet
(Bio-Serv. Inc., Frenchtown, NJ, and Dyets Inc.,
Bethlehem, PA) and water ad libitum with a 12-hr
light and dark daily cycle and they were acclimated
to their environment for at least 1 week before the
start of the experiment.
The experimental regimen using DENA was that
used in previous studies (19). Briefly, the rats were
given DENA (Eastman Kodak Co., Rochester, NY)
200 mg/kg IP dissolved in 0.90/ NaCl solution. After
a 2-week recovery period, they were placed on the
basal diet containing 2-AAF for 1 week, then sub-
jected to a standard PH and continued for an addi-
tional week on the 2-AAF-contained diet. The rats
were returned to the basal diet or a stock rat labor-
atory chow until the termination of the experiment.
The regimen in the Wistar rats used intermittent
periods of feeding diets containing 2-AAF and basal
diet without 2-AAF (20).
At various time periods up to 31 weeks, animals
were anesthetized with ether and the livers rapidly
removed and chilled. Individual or pooled nodules
were dissected free of the surrounding liver and
used for glutathione or glutathione-S-transferase
assays. The surrounding liver and normal controls
on the same diets without the carcinogens were
used.
Results and Discussion
As summarized in Figure 1, hepatocyte nodules
show a metabolic pattern quite different than that
seen in normal or surrounding liver or in livers fol-
lowing exposure to many different inducers in-
cluding carcinogens (3, 21-23). Virtually all xenobi-
otics lead to either no change or most often in-
creases in the activities of one or more of the micro-
somal cytochromes P450, epoxide hydrolase and
the various "drug-metabolizing" enzymes. In addi-
tion, one often sees elevations in glutathione concen-
trations and in activities of one or more glutathione-
S-transferases and UDP-glucuronyltransferase, es-
pecially I.
In contrast, hyperplastic nodules induced by one
of several different carcinogens have been found to
have low levels of cytochromes P450 and of several
microsomal enzyme activities such as aminopyrine
N-demethylase and aryl hydrocarbon hydroxylase
(20, 24-28). Hyperplastic nodules showed a greater
difference from control liver with a respect to N-hy-
droxylation and ring-3-hydroxylation of 2-AAF than
other hydroxylations, indicating a nonuniform de-
crease in the various cytochromes P450 in the nod-
ules (28, 29). Also, diminished significantly are the
levels of interaction of DMN and 2-AAF with pro-
teins, RNA and DNA (30).
Coupled with the decreases in cytochromes P450
and in activities of some drug-metabolizing micro-
somal enzymes are large elevations in selective mi-
crosomal enzymes as epoxide hydrolase (EH) (23, 31)
and in cytosolic glutathione (32), y-glutamyltransfer-
ase (y-GT) (33), some glutathione-S-transferases (34,
35) and UDP-glucuronyltransferase I (34, 36, 37).
So far, no similar pattern of enzyme alteration
has been found in induced livers (Fig. 1). Induced
liver shows either increases or no effect of these
several activities or liver components including mi-
crosomal monooxygenases.
y-GT is high in fetal liver (33), but EH is not in ne-
onatal rat liver (38). Fetal liver is low in cyto-
chromes P450. Also, the pattern of induction of mi-
crosomal 2-AAF-metabolizing enzymes with PB in
fetal liver resembles that seen in nodules (28). How-
ever, glutathione is reported to be low in fetal liver
(39) as is ligandin (40, 41), a major form of gluta-
thione-S-transferase.
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FIGURE 1. Summary of comparison of metabolic patterns in normal liver induced by phenobarbital or many other xenobiotics and
in hyperplastic nodules induced by one of several different chemical carcinogens. The pattern in liver nodules would appear to
be related to the acquisition of a new biochemical program associated with resistance to some inhibitory effects of carcinogens.
The pattern of properties of the nodules to date
appears to be appropriate for a new population that
is resistant to the inhibitory effects of at least some
xenobiotics. The low uptake of at least one hydro-
phobic compound, 2-AAF, the low levels of activa-
tion, the high levels of EH and the elevated levels of
glutathione, y-GT, glutathione-S-transferase and
UDP-glucuronyltransferase all favor minimal up-
take, minimal metabolism and maximal conjugation
of 2-AAF and probably other xenobiotics. This con-
trasts sharply with the patterns seen in fetal or neo-
natal liver or after enzyme induction where in-
creased or equal metabolism is coupled with in-
creasing conjugation.
The hypothesis of resistance based on these bio-
chemical patterns is now worthy of more vigorous
tests. Consistent with this formulation is the obser-
vation that regardless of the way in which the nod-
ules are induced, the patterns are remarkably simi-
lar. This includes use of 2-AAF alone, DENA plus
selection with 2-AAF plus PH or CCL, 3'-methyl-4-di-
methylaminoazobenzene, prolonged ethionine feed-
ing or initiation with DENA followed by promotion
with with choline-methionine-deficient diet for 44
weeks (Ho and Roomi, unpublished results). The ma-
jority of studies were done many weeks or months
after termination of exposure to any xenobiotic.
Thus, it appears that the biochemical patterns seen
in nodules to date are "permanently" imprinted and
not due to any transitory induction.
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